DNA share

DNA listed its shares on Nasdaq Helsinki (the Helsinki Stock Exchange) towards the end of 2016. DNA’s shares were delisted from Nasdaq Helsinki on 3 February 2020.

DNA's dividend policy

DNA's goal is to pay a growing dividend to its shareholders or by other means to return capital equalling 80-100 percent of the net profit for the period. In addition, the Board of Directors may consider the distribution of excess profit to shareholders for a specific financial period. When making the profit distribution decision, the Board of Directors will take into account the company's financial status and financial position as well as future funding needs and financial goals.

  2018 2017 2016 2015 2014 2013
Dividend per share, EUR* 0.70 0.46 0.55 4.72 3.54 4.13
Extra capital payment 0.40 0.64        
Dividend, EUR million 145 145 73 40 30 30
Dividend record date 1 April 2019 26 March 2018 24 March 2017 4 April 2016 30 March 2015 25 March 2014
Dividend payment date 10 April 2019 4 April 2018 7 April 2017 11 April 2016 8 April 2015 3 April 2014

 

*The number of DNA's shares changed when the shares were listed to Helsinki Stock Exchange. From 16 December 2016 the number of the shares has been 132,303,500.